Steve Worland

Steve Worland, Ph.D., is the CEO of Numerion Labs, the AI-native drug discovery company that grew out of Atomwise. A medicinal-chemistry lifer with three decades behind him, his bench work fed the discovery of Paxlovid and Inlyta, and his operating record runs from Agouron through a Roche acquisition to a SPAC. Now he is betting that deep-learning surrogates plus GPU enumeration can search billions of molecules in seconds.